10x Genomics, Inc. TXG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 575.68M | 552.03M | 539.85M | 523.41M | 482.08M |
| Total Receivables | 58.76M | 50.63M | 56.14M | 82.49M | 96.59M |
| Inventory | 64.63M | 52.62M | 53.49M | 56.34M | 61.96M |
| Prepaid Expenses | 19.57M | 19.39M | 20.26M | 22.21M | 19.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 718.63M | 674.67M | 669.73M | 684.45M | 659.83M |
|
|
|||||
| Total Current Assets | 718.63M | 674.67M | 669.73M | 684.45M | 659.83M |
| Net Property, Plant & Equipment | 265.00M | 272.01M | 278.98M | 287.16M | 296.18M |
| Long-term Investments | 6.92M | 6.92M | 4.51M | 4.51M | 4.51M |
| Goodwill | 6.92M | 6.92M | 4.51M | 4.51M | 4.51M |
| Total Other Intangibles | 58.66M | 61.16M | 59.91M | 62.33M | 64.76M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.92M | 15.31M | 2.62M | 2.91M | 2.08M |
| Total Assets | 1.06B | 1.03B | 1.02B | 1.04B | 1.03B |
|
|
|||||
| Total Accounts Payable | 21.59M | 20.69M | 17.43M | 12.73M | 18.07M |
| Total Accrued Expenses | 49.79M | 34.59M | 30.72M | 51.89M | 48.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.95M | 12.02M | 11.33M | 10.99M | 10.54M |
| Total Finance Division Other Current Liabilities | 57.04M | 51.21M | 54.12M | 77.85M | 70.53M |
| Total Other Current Liabilities | 57.04M | 51.21M | 54.12M | 77.85M | 70.53M |
| Total Current Liabilities | 140.37M | 118.51M | 113.60M | 153.45M | 147.32M |
|
|
|||||
| Total Current Liabilities | 140.37M | 118.51M | 113.60M | 153.45M | 147.32M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 63.85M | 66.78M | 70.06M | 73.38M | 76.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.88M | 19.23M | 17.78M | 18.21M | 18.48M |
| Total Liabilities | 225.09M | 204.52M | 201.44M | 245.04M | 242.24M |
|
|
|||||
| Common Stock & APIC | 2.40B | 2.37B | 2.34B | 2.31B | 2.28B |
| Retained Earnings | -1.56B | -1.54B | -1.52B | -1.51B | -1.49B |
| Treasury Stock & Other | 197.00K | 77.00K | 114.00K | 225.00K | 138.00K |
| Total Common Equity | 838.04M | 825.55M | 814.32M | 796.33M | 785.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 838.04M | 825.55M | 814.32M | 796.33M | 785.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 838.04M | 825.55M | 814.32M | 796.33M | 785.12M |
|
|
|||||